| Keller, Michael |
NCT05492851: Trial Comparing Three Single Dose Injections for Knee Osteoarthritis |
|
|
| Terminated | 4 | 6 | US | Zilretta, Synvisc-One 48 MG in 6 ML Prefilled Syringe, Monovisc 88 MG Per 4 ML Prefilled Syringe | Ohio State University | Osteoarthritis, Knee | 01/23 | 01/23 | | |
| Recruiting | 3 | 1000 | Europe, Canada, US, RoW | Ralinepag, APD811, Placebo | United Therapeutics | PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease | 12/25 | 12/25 | | |
ACES, NCT03475212: Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation |
|
|
| Active, not recruiting | 1/2 | 60 | US | Virus Specific T-cell (VST) infusion | Michael Pulsipher, MD | Cytomegalovirus Infections, Adenovirus Infection, EBV Infection | 01/24 | 02/24 | | |
NCT05880888: Investigating the Clinical Impact of a Novel Adipose Allograft Matrix on Knee Fat Pad Impingement Treatment |
|
|
| Active, not recruiting | 1 | 5 | US | Renuva | Ohio State University | Fat Pad Syndrome | 12/24 | 12/24 | | |
NCT03485963: HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals |
|
|
| Active, not recruiting | 1 | 7 | US | HST-NEETs | Catherine Bollard | HIV Infections | 06/24 | 12/24 | | |
NCT04248192: Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST) |
|
|
| Recruiting | 1 | 8 | US | DD HST-NEETs | Catherine Bollard | HIV-Infected Individuals | 09/24 | 04/25 | | |
NCT03180216: T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation |
|
|
| Active, not recruiting | 1 | 32 | US | Virus Specific T cells (VSTs) | Children's National Research Institute | Viral Infections, Bone Marrow Transplant Infection | 03/26 | 11/26 | | |
ATLANTIC, NCT04691622: Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts |
|
|
| Recruiting | 1 | 48 | US | Norovirus -specific T-cell (NST) therapy | Children's National Research Institute | Viral Infection, Hematopoietic Stem Cell Transplantation (HSCT), Primary Immunodeficiency Disorders (PID) | 08/25 | 10/26 | | |
TONI, NCT05141058: T CELL THERAPY OPPOSING NOVEL COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS |
|
|
| Recruiting | 1 | 24 | US | Coronavirus-specific T cell (CST) | Children's National Research Institute | SARS-CoV-2 Infection | 11/25 | 12/27 | | |
NCT03878069: Registry Study of Revcovi Treatment in Patients With ADA-SCID |
|
|
| Completed | N/A | 32 | US | elapegademase-lvlr, Revcovi | Chiesi Farmaceutici S.p.A. | Adenosine Deaminase Severe Combined Immunodeficiency | 01/23 | 01/23 | | |
NCT04861714: Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR) |
|
|
| Active, not recruiting | N/A | 75 | US | Regeneten, Standard repair | Ohio State University, Smith & Nephew, Inc. | Arthroplasty, Replacement, Shoulder | 12/24 | 04/25 | | |
NCT05492396: Evaluation of Healing Following Open Gluteus Medius Repair With Biointegrative Implant |
|
|
| Recruiting | N/A | 30 | US | Standard gluteus medius repair with Tapestry Biointegrative implant | Ohio State University | Hip Injuries, Tendon Injuries, Orthopedic Procedures | 06/25 | 12/25 | | |
NCT06388993: Marrow Cellution™ vs. Traditional BMA Harvest Project |
|
|
| Recruiting | N/A | 6 | US | Bone Marrow Collection | Ohio State University | Hip Arthropathy, Avascular Necrosis of Bone, Subchondral Cysts | 12/24 | 03/25 | | |
ARC, NCT03295994: Operative Versus Non-Operative Treatment for Atraumatic Rotator Cuff Tears |
|
|
| Active, not recruiting | N/A | 189 | US | Operative, Non-Operative | University of Michigan, Patient-Centered Outcomes Research Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Rotator Cuff Tear | 02/25 | 11/26 | | |
| Recruiting | N/A | 20000 | US | | National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Mental Health (NIMH) | Atopy, Primary Immunodeficiency, Autoimmunity, Autoinflammation | 12/29 | 12/29 | | |
NCT03394053: The Mechanistic Biology of Primary Immunodeficiency Disorders |
|
|
| Recruiting | N/A | 2500 | US | | National Institute of Allergy and Infectious Diseases (NIAID) | Primary Immunodeficiency Disorders | 12/29 | 12/42 | | |
| Jain, Tania |
| Recruiting | 3 | 350 | Europe, Canada, US, RoW | Selinexor, KPT-330, Placebo, Ruxolitinib | Karyopharm Therapeutics Inc | Myelofibrosis | 09/25 | 03/28 | | |
|
|
|
|
|
|
ALLOHA, NCT05473910: A Study of TSC-100 and TSC-101 in AML, ALL and MDS Patients Undergoing Haploidentical Donor Transplantation |
|
|
| Recruiting | 1 | 63 | US | SOC + TSC-100, SOC + TSC-101, Control | TScan Therapeutics, Inc. | AML, Myelodysplastic Syndromes, ALL, Adult | 12/25 | 06/26 | | |
TONI, NCT05141058: T CELL THERAPY OPPOSING NOVEL COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS |
|
|
| Recruiting | 1 | 24 | US | Coronavirus-specific T cell (CST) | Children's National Research Institute | SARS-CoV-2 Infection | 11/25 | 12/27 | | |
